On-Demand Webinars
-
HPAPIS Production: "Where Micrograms Matters"
4/13/2026
In HPAPI manufacturing, micrograms make a difference. Risk‑based containment, smart facility design, and exposure limits safeguard people, product, and performance.
-
From Bench To Approval: Smart IVBE Strategies For Complex Drugs
4/10/2026
In vitro bioequivalence can replace clinical studies for complex products when well designed. Clinically relevant, risk-based methods under realistic conditions show site-of-action equivalence.
-
From Fermentation To Vaccination
4/8/2026
Non-animal-origin squalene is gaining momentum in vaccine adjuvants. See how fermentation-derived squalene delivers comparable performance, strong stability, and regulatory alignment.
-
From Clinical To Commercial: Introducing Devices Earlier To Streamline The DDC Journey
4/8/2026
Uncover how early device strategy and integrated planning can streamline development, reduce risk, and accelerate your path to commercial success.
-
Unlocking The Benefits Of Customs Warehouse For Pharmaceutical Supply Chains
4/8/2026
Learn how leveraging a customs warehouse can streamline your supply chain, reduce VAT costs, and enhance global compliance and efficiency.
-
Balancing Quality, Efficiency, And Cost In Manufacturing
3/26/2026
Learn strategies to strengthen global biologics manufacturing through consistent quality, advanced technologies, and efficient tech transfer to improve operations and commercial readiness.
-
Ensure Successful Viral Clearance
3/26/2026
A decade of viral clearance data comparing established and emerging operations, highlighting LRV performance, key process risks, and practical insights to strengthen downstream safety.
-
Deciphering The Complexity Of Therapeutic Biologics
3/26/2026
This session breaks down essential analytical approaches that strengthen biologics development, from defining critical quality attributes to supporting comparability and regulatory readiness.
-
Unlock The Potential Of GPEx Lightning Accelerate Your HEK Cell Line Development
3/25/2026
Discover how an advanced cell line development platform now supports HEK cells alongside CHO, enabling rapid, scalable production of complex biologics while saving up to 12 weeks on development timelines.
-
Flexible Therapeutic Development: Balancing Speed, Cost, and Process
3/24/2026
Microbial development for first‑in‑human studies requires coordinated cell line, fermentation, and purification strategies to accelerate timelines while controlling cost and process robustness.